# A Prospective, Randomized Controlled Trial Comparing Traditional Methods of Neuromuscular Block Reversal to Sugammadex for Extubation in the Operating Room in ASA 4 and 4E Patients

> **NCT01761552** · PHASE4 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 130 (estimated)

## Conditions studied

- Neuromuscular Blockade

## Interventions

- **DRUG:** Sugammadex Reversal
- **DRUG:** Atropine/Neostigmine

## Key facts

- **NCT ID:** NCT01761552
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2013-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761552, "A Prospective, Randomized Controlled Trial Comparing Traditional Methods of Neuromuscular Block Reversal to Sugammadex for Extubation in the Operating Room in ASA 4 and 4E Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01761552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*